This would be achieved over the expected remaining life years of the vaccinated population, amounting to a period of around 19 years.
The report was produced by the Office for Health Economics in the UK, commissioned by pharmaceutical firm GSK and launched at Leinster House today. The study considered adult vaccines and their programmes as recommended by the National Immunisation Advisory Committee.The report looked at the benefit of offering it to people aged 50 years and above.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: